Over 600 researchers from all round Europe have contributed to a critical review of Horizon 2020. They say collaboration is needed across disciplines for the €80B research programme to deliver, writes EMRC Chair Liselotte Højgaard
An Imperial College London study, for the Science|Business Innovation Board, looks at how professional investors pick winners – and draws some lessons for government funders
It’s often hard to quantify, but angel investing is a growing around the world. New data indicate this will be key to overcoming the growth challenges facing entrepreneurs, says the OECD's Karen Wilson
Alan Leshner, CEO of the American Association for the Advancement of Science, caused a stir at February’s EU ministerial conference in Copenhagen, with a hard-hitting speech on the state of US science. America's scientific eminence, 'is at risk' he said.
Hard-pressed healthcare systems can no longer pay premium prices for new drugs. The consequence will be less innovation in Europe says Andrew Witty, CEO of GlaxoSmithKline.
Only world-class science will deliver the innovation and growth Europe so desperately needs. US experience can help EU policy makers understand how to enhance R&D productivity and encourage excellence, says Paula Stephan
eHealth provides the means to reduce costs and improve the quality of our healthcare systems. It is now time for policy makers to take concrete measures to scale-up and accelerate adoption of technologies for real impact, says Elena Bonfiglioli
UK innovation strategy is changing, with a move away from across-the-board generic support, and a return to picking winners and promoting particular technologies
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.